Quest Diagnostics stock pre-market at EUR 206.40: plus 0.22 percent
Published on 10/01/2026 at 08:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Quest Diagnostics stock was at EUR 206.40 in pre-market trading at Lang & Schwarz on October 1, 2026, at 8:27 a.m. CEST. That was an increase of 0.22 percent versus the Lang & Schwarz prior close of EUR 205.95 on September 30, 2026.
Pre-market trading
The Lang & Schwarz bid was EUR 204.80 and the ask was EUR 208.00. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Quest Diagnostics stock.
Previous close
The previous Lang & Schwarz closing price was EUR 205.95 on September 30, 2026. The current pre-market indication and the prior close are both euro prices from Lang & Schwarz.
Apple Health integration
Quest Diagnostics announced on September 9, 2026, that Apple Health users in the United States will later this year be able to purchase a Quest laboratory test panel through the app. The panel includes more than 50 biomarkers, and users can purchase and schedule testing at one of Quest's approximately 2,000 U.S. patient service centers for USD 119, according to the Quest Diagnostics release published by PR Newswire.
